Today, more than half of all patients diagnosed with cancer can be cured. Cancer care specialists in Tunisia are reaching new heights by providing the correct diagnosis and a personalized treatment plan from the start.
Cancer care doctors in Sousse have unparalleled expertise in diagnosing and treating all types of cancer, and are implementing the latest technology and the most advanced, personalized medicine to increase the survival rate.
As a leading destination for cancer therapies, Tunisia takes great pride in the compassion and dedication to discovering the future of cancer treatment. Progressive technology enables pathologists in Tunisia to foresee a tumor's aggressiveness, as well as to detect genetic abnormalities in some tumors, which leads to the most suitable course of treatment.
Another development in Tunisian cancer therapies shows that radiation therapy with chemotherapy makes tumor cells more sensitive to the effects of radiation — further enhancing the success of therapy.
Spotlight — Centre Médical Ibn Khaldoun Sousse
The number one objective of Tunisian cancer specialists at the Centre Médical Ibn Khaldoun is to understand at the most fundamental levels of how cancer arises and spreads, and to apply this information to progress advanced ways to detect, treat, and prevent cancer.
The Centre Médical Ibn Khaldoun in Sousse was established in 2005 to meet a need in terms of care for tumors. The center comprises of modern equipment and new technological processes adapted to better treat tumors. The committed team in Sousse provides patient the necessary support and treatment in respectable conditions, combining efficiency and comfort.
The center welcomes patients from around the globe. At the Centre Médical Ibn Khaldoun, the goal is to support cancer patients in getting the most-effective resources for arising medical needs as efficiently as possible. Using this approach, personalized treatment plans reflect in the expertise of many doctors — surgeons, medical oncologists, radiologists, radiation oncologists, and pathologists.
Treatments are offered for prostate cancer, pancreatic cancer, oral cancer, genealogical cancers, colon cancer, radioactive iodine therapy, urologic and stomach cancers.
Trending — Surviving the Disease
In a recent interview, Physician-In-Chief and Chief Medical Officer of Memorial Sloan Kettering Cancer Center, Dr. Jose Baselga, discussed how personalized medicine is rapidly progressing cancer treatment options and helping more patients survive the disease.
"We know that every cancer is different and now we can begin to design therapies and treatment that are really cool and that are specific for every personal cancer," stated Dr. Baselga. “Identifying genetic mutations that are the driving mechanism of an individual patient's cancer -- can help provide the right treatments. As many as 60 percent of Memorial Sloan Kettering's breast cancer patients are likely to receive more effective treatment thanks to progress in genomic research.”
Immunotherapies are a key component to the ever-changing options for cancer treatment. If oncologists are able to identify multiple mutations in a tumor, they can govern the patient's immune system to fight the cancer, an approach that's worked well for melanoma and lung cancer.
Baselga further stated, “with the knowledge of today, and science, the prospects are limitless."